A nutrition-tech company from Utah has pulled off a feat that few global tech giants ever manage: three-for-three "All-A, All-Yes" international search reports; WIPO published the applications today.
WOODS CROSS, UT, UNITED STATES, July 23, 2026 /EINPresswire.com/ — IndulgeRx Brands Inc. ("IndulgeRx"), a privately held company funded by its founder and friends and family that focuses on nutrition technology, revealed today that the World Intellectual Property Organization (WIPO) has formally published all three of its Patent Cooperation Treaty (PCT) patent applications covering the AI-powered IRX FOODSCORE® platform. Each application independently secured an "all-A" International Search Report (ISR) from the U.S. International Searching Authority (ISA/US), with every claim judged to be novel, inventive, and industrially applicable.
What Exactly Took Place
Every AI or health-tech patent application undergoes review by a professional patent searcher who searches globally for prior inventions that could block or duplicate the claims. Citations receive grades: "X" indicates a discovery that could kill the invention, "Y" means a combination of existing concepts could undermine the claims, and "A" signals background information posing no real obstacle to patentability.
Across all three IndulgeRx applications—covering the platform as a system, as software, and as a business method—the examiner found zero "X" and zero "Y" citations. Every reference came back "A," and each Written Opinion confirmed novelty, inventive step, and industrial applicability for claims 1–15.
The government (ISA) patent examiner's own written conclusions highlight the strength of the outcome: even after merging every piece of prior art the examiner could locate, the reviewer determined that assembling them "would be impermissible hindsight"—patent language for reverse-engineering an answer only possible in retrospect. And even where existing technology touched isolated parts of the puzzle, the examiner found that combining them "would not provide any advantages over the present application, or would require a complexity beyond the level of ordinary skill."
Each published application is now publicly accessible via WIPO PATENTSCOPE:
• IRX FS SOFTWARE – WO2026156106 A1
• IRX FS METHOD – WO2026156110 A1
• IRX FS SYSTEM – WO2026156104 A1
Perspectives on the Achievement
"For a nine-year, self-funded company to walk into the same global patent examination process that Google, Amazon, and Oracle face, and come out with a cleaner search result than most well-funded startups ever see, is validation money can't manufacture," said John L. Hastings III, CEO and Founder of IndulgeRx Brands Inc. "IRX FOODSCORE® isn't a feature bolted onto someone else's technology. It's genuinely new, and now the world can see that for itself; changing the way the world eats, one byte at a time."
"An independent patent examiner tested IRX's technology against the biggest names in health AI, including Medtronic, Oracle, Salesforce, Cornell, and others, and could not identify any single reference or combination that defeats it," said Richard D. Clarke, Esq., IndulgeRx's patent counsel. "That is now a matter of public WIPO record, with a locked priority date of January 16, 2025 that predates every future copycat." Patent counsel further notes one filing required a minor procedural claim-grouping clarification that did not affect the 'A' grades or any novelty findings, simply underscoring that this achievement rests on substance, not a technicality.
Why This Is Significant — For Every Type of Investor
For IRX friends, family, and individual backers who provided early funding, this is independent, government-verified proof that a small, mission-driven team can out-innovate giants with far greater resources. For institutional investors and strategic acquirers, this milestone materially de-risks the IP moat underpinning IndulgeRx's twelve monetizable vantage points: consumer apps, CPG licensing, retail, payers and providers, pharmacists, sports performance, researchers, and government agencies. It also strengthens the company's value propositions and market positioning ahead of seed round and Series A investment discussions and strategic partnership conversations.
IRX FOODSCORE® analyzes an individual's health history, age, gender, medications, and goals against ingredients, additives, preservatives, and preparation methods to generate two personalized numbers: a Relevant Nutrition Score (RNS) and a Relevant Risk Score (RRS), turning “is this good for me?” into one actionable IRX FOODSCORE® answer, anywhere in the world.
For more information about IndulgeRx Brands Inc. and IRX FOODSCORE®, visit www.indulgerx.com and www.indulgerx.com/irx-foodscore, or www.fightbackfoods.com.
Joe Darnell
IndulgeRx Brands, Inc
+1 801-683-8769
email us here
